ARCHIVES

Aranesp Improved Anemia In MDS In Phase II Trial

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Two Breast Cancer Treatments Show Similar Benefit In Trial

December 30, 2005

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

May 2, 2008

NCI Cooperative Group Clinical Trials Approved

May 29, 2009

NCI advisors approve recompetition of $62 million phase II contracts program.

November 19, 2004

NCI Outlines Need For $3,873 Billion To Seize Cancer Research Opportunities

October 30, 1998

IL-2 Trials Proliferate; Biotherapeutics Sees NCI Proposal As Vindication Of Its Policies

May 8, 1987